Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Wave Life Sciences, Inc. before investing.

In this article, we go over a few key elements for understanding Wave Life Sciences, Inc.’s stock price such as:

• Wave Life Sciences, Inc.’s current stock price and volume
• Why Wave Life Sciences, Inc.’s stock price changed recently
• Upgrades and downgrades for WVE from analysts
• WVE’s stock price momentum as measured by its relative strength

About Wave Life Sciences, Inc. (WVE)

Before we jump into Wave Life Sciences, Inc.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

Wave Life Sciences, Inc., a clinical-stage biotechnology company, focuses on unlocking the potential of ribonucleic acid (RNA) medicines to transform human health. Its RNA medicines platform, PRISM, combines RNA medicine modalities, chemistry innovation, and deep insights in human genetics to deliver scientific breakthroughs that treat rare and common disorders. Its pipeline focuses on obesity (WVE-007), alpha-1 antitrypsin deficiency (AATD) (WVE-006), and PNPLA3 I148M liver disease (WVE-008) programs; and clinical programs for Duchenne muscular dystrophy and Huntington’s disease, as well as various preclinical programs utilizing its RNA medicines platform. Wave Life Sciences, Inc. was founded in 2012 and is headquartered in Cambridge, Massachusetts.

Want to learn more about Wave Life Sciences, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Wave Life Sciences, Inc..

Wave Life Sciences, Inc.’s Stock Price as of Market Close

As of September 03, 2026, 12:15 PM, CST, Wave Life Sciences, Inc.’s stock price was $4.680.

Wave Life Sciences, Inc. is down 4.1% from its previous closing price of $4.880.

During the last market session, Wave Life Sciences, Inc.’s stock traded between $4.645 and $4.960. Currently, there are approximately 204.01 million shares outstanding for Wave Life Sciences, Inc..

Wave Life Sciences, Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

Wave Life Sciences, Inc. Stock Price History

Wave Life Sciences, Inc.’s (WVE) price is currently down 4.49% so far this month.

During the month of September, Wave Life Sciences, Inc.’s stock price has reached a high of $5.090 and a low of $4.645.

Over the last year, Wave Life Sciences, Inc. has hit prices as high as $21.730 and as low as $4.660. Year to date, Wave Life Sciences, Inc.’s stock is down 72.47%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Wave Life Sciences, Inc. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of September 02, 2026, there were 2 analysts who downgraded Wave Life Sciences, Inc.’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate Wave Life Sciences, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Wave Life Sciences, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Wave Life Sciences, Inc.’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Wave Life Sciences, Inc. (WVE) by visiting AAII Stock Evaluator.

Relative Price Strength of Wave Life Sciences, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of September 02, 2026, Wave Life Sciences, Inc. has a weighted four-quarter relative price strength of -5.68%, which translates to a Momentum Score of 32 and is considered to be Weak.

Want to learn more about how Wave Life Sciences, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Wave Life Sciences, Inc. Stock Price: Bottom Line

As of September 3, 2026, Wave Life Sciences, Inc.’s stock price is $4.680, which is down 4.1% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Wave Life Sciences, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.